Expiratory Flow Accelerator (Efa) vs Efa + High Flow in Chronic COPD and Bronchiectasis
NCT ID: NCT06017739
Last Updated: 2024-02-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2023-10-09
2025-01-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Respiratory Strategies in COPD Patients With Persistent Hypercapnia Following Exacerbation
NCT07065799
High Flow Nasal Cannula and Hypercapnia
NCT03759457
Benefit of High-flow Nasal Cannula on Persistent Dyspnea in Ild
NCT06617078
Combination of NHF and Nebulizer on Lung Function in COPD
NCT02885103
Physiotherapy With Positive Expiratory Pressure (PEP) Bottle in Patients With Bronchiectasis
NCT06820918
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
1. EFA / EFA + High Flow
2. EFA + High Flow / EFA patients are randomly assigned to one of two groups
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Expiratory Flow Accelerator
Patients for 6 weeks use the Expiratory Flow Accelerator Technology
Bronchial Clearance A
EFA technology: the patient has to breathe at tidal volume by a mouthpiece at level 5 for half an hour twice a day.
Expiratory Flow Accelerator + HIGH FLOW Technology
Patients for 6 weeks use the EFA technology and High Flow Technology
Bronchial Clearance B
High Flow Technology: patient has to wear nasal cannula and breathe his nose for one hour twice a day. After he has to use EFA technology level 5 for half an hour twice a day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bronchial Clearance A
EFA technology: the patient has to breathe at tidal volume by a mouthpiece at level 5 for half an hour twice a day.
Bronchial Clearance B
High Flow Technology: patient has to wear nasal cannula and breathe his nose for one hour twice a day. After he has to use EFA technology level 5 for half an hour twice a day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Bronchiectasis diagnosed by CT
* 2 Exacerbation/year
Exclusion Criteria
* OSAS
* Non Invasive Ventilation
* Ineffective Cough
* Exacerbation in progress
* Hemodynamic Instability
* severe heart failure
18 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Socio Sanitaria Territoriale della Valle Olona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
MARIANNA MESSINA
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marianna Messina
Role: PRINCIPAL_INVESTIGATOR
ASST Valle Olona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marianna Messina
Somma Lombardo, Varese, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
759del07/08/23
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.